Hematological Malignancies Collection

The Molecular Cancer Research editors proudly present this collection of Hematological Malignancies articles recently published in the Journal.

• IGH/MYC translocation associates with BRCA2 deficiency and synthetic lethality to PARP1 inhibitors.
  Maifrede S…Skorski T. Molecular Cancer Research 2017.
• Quantitative proteome heterogeneity in myeloproliferative neoplasm subtypes and association with JAK2 mutation status.
  Socoro-Yuste N…Mossuz P. Molecular Cancer Research 2017.
• Expression profiling of circulating microvesicles reveals intercellular transmission of oncogenic pathways.
  Milani G…Te Kronnie G. Molecular Cancer Research 2017.
• Combined TRAF6 targeting and proteasome blockade has anti-tumor and anti-bone resorptive effects.
  Chen H…Berenson JR. Molecular Cancer Research 2017.
• Comprehensive transcriptome and mutational profiling of endemic burkitt lymphoma reveals EBV type-specific differences.
  Kaymaz Y…Bailey JA. Molecular Cancer Research 2017.
• Constitutive phosphorylation of STAT3 by the CK2-BLNK-CD5 complex.
  Rozovski U…Estrov Z. Molecular Cancer Research 2017.
• EZH2 or HDAC1 inhibition reverses multiple myeloma–induced epigenetic suppression of osteoblast differentiation.
  Adamik J…Galson DL. Molecular Cancer Research 2017.
• LIN28B activation by PRL-3 Promotes leukemogenesis and a stem cell–like transcriptional program in AML.
  Zhou J…Chng WJ. Molecular Cancer Research 2017.
• Nuclear import of JAK1 Is mediated by a classical NLS and is required for survival of diffuse large B-cell lymphoma.
  Zhu F…Rui L. Molecular Cancer Research 2017.
• Src family kinases are regulated in multiple myeloma cells by phosphatase of regenerating Liver-3.
  Abdollahi P…Børset M. Molecular Cancer Research 2017.